NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Drug Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Beth Israel Deaconess Medical Center, Boston, U.S.



Studies from Beth Israel Deaconess Medical Center, Boston, U.S. highlight latest findings



November 7th, 2006

Studies from Beth Israel Deaconess Medical Center, Boston, U.S. highlight latest findings.

This trend article about Beth Israel Deaconess Medical Center, Boston, U.S. is an immediate alert from LawRx to identify developing directions of research.

Study 1: Performance of mandatory angiographic followup increases rates of target vessel revascularization among patients receiving both bare-metal stents and paclitaxel-eluting stents (PES) and overestimates the absolute clinical benefits of PES relative to clinical followup alone.

According to recent research from the United States, "The objectives of the study were to evaluate the...


Source: Drug Law Weekly (2006-11-07)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login